drugset
drugset / Trial / NCT01451229

Pharmacokinetics and Pharmacodynamics of Higenamine in Chinese Healthy Subjects

NCT01451229 ↗

Phase 1 Completed 10 enrolled Peking Union Medical College Hospital
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the pharmacokinetics and pharmacodynamics of higenamine in healthy Chinese subjects

Timeline

Start
2009-06
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject higenamine Unknown 0.5 ug/kg Intravenous
Subject higenamine Unknown 1 ug/kg Intravenous
Subject higenamine Unknown 2 ug/kg Intravenous
Subject higenamine Unknown 4 ug/kg Intravenous

Indications

No indication recorded.